Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.

The Korean journal of hepatology - 1 Sept 2009

Jeong Soung Won, Kim Jin Dong, Woo Hyun Young, You Chan Ran, Lee Sung Won, Song Myeong Jun, Jang Jung Won, Bae Si Hyun, Choi Jong Young, Yoon Seung Kew

Abstract excerpt

BACKGROUND/AIMS: Various predictive factors for peginterferon alpha and ribavirin therapy in chronic hepatitis C have been reported, but the effect of adherence to therapy has not been established. We investigated how adherence affects the sustained virologic response (SVR). METHODS: We analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Patient Compliance

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 19783883
DOI: 10.3350/kjhep.2009.15.3.338

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19783883-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.PMID 19783883Read ↗

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.Semantic proximity Read ↗

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.Semantic proximity Read ↗

[Importance of medication adherence to peginterferon-ribavirin combination therapy in patients with chronic hepatitis C].Semantic proximity Read ↗

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin.Semantic proximity Read ↗

Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.Semantic proximity Read ↗

Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.Semantic proximity Read ↗

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.Semantic proximity Read ↗

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice.Semantic proximity Read ↗

The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis C patients with genotype 1.Semantic proximity Read ↗

Optimizing treatment regimens in hepatitis C.Semantic proximity Read ↗

Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C.Semantic proximity Read ↗

Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.